US Stock MarketDetailed Quotes

Virpax Pharmaceuticals (VRPX)

Watchlist
  • 0.0004
  • 0.00000.00%
15min DelayClose May 14 13:55 ET
497.00Market Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virpax Pharmaceuticals (VRPX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Net income from continuing operations
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Change In working capital
-199.78%-4.78M
-67.16%512.2K
-177.67%-2.45M
143.70%1.73M
-629.08%-4.58M
56.62%4.79M
21.72%1.56M
57.98%3.15M
-21.29%711.59K
43.85%-628.42K
-Change in prepaid assets
131.96%444.28K
0.01%398.6K
6.39%278.72K
51.62%544.4K
6.11%-777.44K
-90.67%191.53K
-83.36%398.56K
-2.31%261.97K
-40.90%359.06K
32.04%-828.07K
-Change in payables and accrued expense
29.35%775.35K
-29.57%113.6K
-96.24%-223.81K
237.49%1.19M
-252.36%-304.18K
160.36%599.43K
105.18%161.3K
-106.61%-114.05K
18.90%352.53K
101.26%199.65K
-Change in other current liabilities
-250.00%-6M
--0
-183.33%-2.5M
--0
---3.5M
100.00%4M
-50.00%1M
--3M
--0
--0
Cash from discontinued investing activities
Operating cash flow
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
9.08M
4.37M
2.62M
1.65M
453.95K
0
0
0
0
0
Net common stock issuance
--6.32M
--4.07M
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--2.77M
--68
--2.77M
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
---151.3K
---601.8K
--453.95K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--9.08M
--4.37M
--2.62M
--1.65M
--453.95K
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-51.87%9.14M
-99.86%17.23K
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-48.44%19M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
Current changes in cash
22.58%-7.63M
149.67%1.5M
30.08%-1.85M
100.21%4.6K
-262.25%-7.28M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
End cash Position
-83.45%1.51M
-83.45%1.51M
-99.86%17.23K
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
Free cash flow
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Net income from continuing operations 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Change In working capital -199.78%-4.78M-67.16%512.2K-177.67%-2.45M143.70%1.73M-629.08%-4.58M56.62%4.79M21.72%1.56M57.98%3.15M-21.29%711.59K43.85%-628.42K
-Change in prepaid assets 131.96%444.28K0.01%398.6K6.39%278.72K51.62%544.4K6.11%-777.44K-90.67%191.53K-83.36%398.56K-2.31%261.97K-40.90%359.06K32.04%-828.07K
-Change in payables and accrued expense 29.35%775.35K-29.57%113.6K-96.24%-223.81K237.49%1.19M-252.36%-304.18K160.36%599.43K105.18%161.3K-106.61%-114.05K18.90%352.53K101.26%199.65K
-Change in other current liabilities -250.00%-6M--0-183.33%-2.5M--0---3.5M100.00%4M-50.00%1M--3M--0--0
Cash from discontinued investing activities
Operating cash flow -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 9.08M4.37M2.62M1.65M453.95K00000
Net common stock issuance --6.32M--4.07M--0----------0--0--0--------
Proceeds from stock option exercised by employees --2.77M--68--2.77M----------0--0--0--------
Net other financing activities -----------151.3K---601.8K--453.95K--------------------
Cash from discontinued financing activities
Financing cash flow --9.08M--4.37M--2.62M--1.65M--453.95K--0--0--0--0--0
Net cash flow
Beginning cash position -51.87%9.14M-99.86%17.23K-87.36%1.87M-89.01%1.87M-51.87%9.14M-48.44%19M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M
Current changes in cash 22.58%-7.63M149.67%1.5M30.08%-1.85M100.21%4.6K-262.25%-7.28M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
End cash Position -83.45%1.51M-83.45%1.51M-99.86%17.23K-87.36%1.87M-89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M
Free cash flow -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +28.67%
Sample Name
Sample Code
 +23.05%
Sample Name
Sample Code
 +22.42%
4
United Sts Brent Oil Fd Lp Unit
BNO
+21.50%
5
ProShares Ultra Energy
DIG
+19.88%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.81%
Sample Name
Sample Code
 +5.47%
Sample Name
Sample Code
 +3.50%
4
Hesai
HSAI
+0.96%
5
MINISO
MNSO
-0.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -